Literature DB >> 19276637

Serum obestatin/ghrelin ratio is altered in patients after distal gastrectomy.

Sung Kim1, Jun Haeng Lee, Jin Seok Heo, Min Jung Kwak, Su Jin Kim, Young Bae Sohn, Sang Eun Kim, Sang Yong Song, Yon Ho Choe, Ji Won Baek, Mi Yong Rha, Yoo Joung Oh, Dong-Kyu Jin.   

Abstract

BACKGROUND/AIMS: Ghrelin is a peptide hormone produced mainly in the stomach, and obestatin is derived by proteolytic cleavage of the ghrelin prepro-hormone. The aim of this study was to determine the postoperative serial changes in these hormones and whether hyperplasia of ghrelin-expressing cells occurs in the remnant stomach.
METHODS: We prospectively analyzed serial serum samples of 45 early gastric cancer patients and remnant stomach samples of 24 patients. RESULT: The serum obestatin level on day 2 was lower than that on day 0, and it subsequently returned to the level observed on day 0. In contrast, the serum ghrelin level was lower on days 120 and 210 than on day 0. Eventually, the obestatin/ghrelin ratio was significantly high on day 210 (p = 0.0003). Moreover, we did not observe an increase in the number of ghrelin-expressing cells. The number of ghrelin-expressing cells correlated with the serum ghrelin level.
CONCLUSION: The serum level of obestatin and ghrelin exhibits a different time course in patients who have undergone gastrectomy, and there was no ghrelin-expressing cell hyperplasia in the remnant stomach despite the decrease in serum ghrelin. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19276637     DOI: 10.1159/000207507

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  5 in total

1.  Ghrelin and gastrin in advanced gastric cancer before and after gastrectomy.

Authors:  Anna Zub-Pokrowiecka; Kazimierz Rembiasz; Peter C Konturek; Andrzej Budzyński; Stanisław J Konturek; Marek Winiarski; Władysław Bielański
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

2.  The effect of continuous jejunal interposition on gastrointestinal hormones after distal gastrectomy.

Authors:  Zhen-Ye Lv; Zai-Yuan Ye; Qin-Shu Shao; Wei Zhang; Qin Zhang; Yuan-Shui Sun; Shu-Guang Li; Yuan-Yu Wang; Ji Xu
Journal:  Bosn J Basic Med Sci       Date:  2012-02       Impact factor: 3.363

Review 3.  Clinical application of ghrelin administration for gastric cancer patients undergoing gastrectomy.

Authors:  Shuji Takiguchi; Akihiro Takata; Kohei Murakami; Yasuhiro Miyazaki; Yoshitomo Yanagimoto; Yukinori Kurokawa; Tsuyoshi Takahashi; Masaki Mori; Yuichiro Doki
Journal:  Gastric Cancer       Date:  2013-09-20       Impact factor: 7.370

4.  Diagnostic value of serum levels of galanin and obestatin in patients with gastric cancer.

Authors:  Furkan Ali Uygur; Esra Dişçi; Rıfat Peksöz; Nurinnisa Öztürk; Mehmet İlhan Yildirgan; Yavuz Albayrak
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-07       Impact factor: 1.712

5.  Postoperative Body Mass Index Changes in Gastric Cancer Patients according to Reconstruction Type: Effectiveness of Long Jejunal Bypass on Weight Loss in Obese Patients after Distal Gastrectomy.

Authors:  Ji Won Kim; So Young Jung; Ji Woong Cho; Byung Chun Kim; Kyung Suk Chung; Dae Hyun Yang
Journal:  Indian J Surg       Date:  2012-07-08       Impact factor: 0.656

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.